Avinash Das Sahu, PhD, post graduate student in Department of Data Science to Dana-Farber Cancer Institute, was awarded the Michelson award 2019 by the Michelson Medical Research Foundation and the Human Vaccines Project. It is among the three young scientists who received the Michelson awards in 2019: everyone will receive $ 150,000 for their new approaches to decipher how the human immune system fights disease.
"The Michelson Prizes have been established to allow early childhood scientists to pursue disruptive, high-risk and innovative ideas that have the potential for a high impact in areas of disease and that probably would not be funded by traditional grant mechanisms," she says. Gary Michelson, MD, founder of the Michelson Medical Research Foundation. "The winners of this year truly represent the next generation of innovative scientists, building the toolkit with which humanity can pursue longer and healthier lives."
Sahu was recognized for his project entitled "Identification of anticancer drugs that increase the immune response." He is building new frameworks for deep learning of artificial intelligence (Artificial Intelligence) to devise new therapeutic strategies for cancer immunotherapy, with potential applications in human immunology.
"We are witnessing a paradigm shift in human immunology, since the convergence of computational tools, artificial intelligence and machine learning joins the advances of genomics and immunobiology to offer an unprecedented opportunity at the innovation, "says Wayne Koff, CEO of the Human Vaccines Project. "The Michelson award winners of this year reflect this change, bringing ideas that could truly transform the way we fight major global diseases."
The Michelson awards recognize researchers under the age of 35 who are conducting research on the next frontiers of human immunology, using the technological advances of genomics, computational biology and machine learning to work to transform the future of human health. The winners of this year have been selected from a global competition that included over 150 applications in 35 countries. The recipients of the award will receive their awards on June 18, 2019, at the University of California, Los Angeles, where they will also participate in a symposium sponsored by the Human Vaccines, The Future of Vaccine and Immunotherapy Development project: Towards a Artificial Driven Model of the human immune system.
The other 2019 winners include:
- Murad Mamedov, University of California, San Francisco (UCSF), for his project entitled "Mapping γδ Ligands Receptor of T cells". It is using genetic modification technologies to create a new platform for understanding an important group of immune cells that can provide keys for the diagnosis, prevention and treatment of infectious and non-communicable diseases such as cancer.
- Kamal Mandal, UCSF, for his project entitled "Structural Surfaceomics" an approach to identify the conformations of cancer-specific cell surface proteins for immunotherapeutic targeting. "It is developing new technologies that identify the form of proteins that could provide new targets for cancer immunotherapy, with potential applications to other diseases.
/ Public release. View in full Here.
(tagToTranslate) Dana-Farber Cancer Institute (t) cancer (t) California (t) artificial intelligence (t) medical research (t) immunotherapy (t) intelligence (t) gene-editing (t) university (t) scientists (t ) the innovation (t) the research (t) the humanity (t) of the project (t) of illness (t) the vaccine